Teva Investigational Site 167 — Richland, Washington

Teva Investigational Site 167 is a clinical research site located in Richland, Washington, United States 99352.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Teva Investigational Site 167 has participated in 2 clinical trials.

Therapeutic areas: Tardive Dyskinesia.

Sponsors: Auspex Pharmaceuticals, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Richland

Browse all research sites in Washington · View every site in Richland

• Zain Research LLC
• Mid-Columbia Research
• Research Site
• GSK Investigational Site
• Novo Nordisk Investigational Site
• Kadlec Regional Medical Center
• Synergy Research Site
• Chiesi Investigational Site
• Pacific Northwest National Laboratory
• Novartis Investigative Site
• Ra0098 133

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Teva Investigational Site 167?

Teva Investigational Site 167 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Teva Investigational Site 167 conducted?

Teva Investigational Site 167 has 2 clinical trials on record. Their work covers Tardive Dyskinesia.

Is Teva Investigational Site 167 accredited by Crixeo Clinical Trials?

Teva Investigational Site 167 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Teva Investigational Site 167?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.